You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In a PrecisionFDA challenge, DeepVariant calls of PacBio HiFi reads topped 99 percent precision and recall for SNVs and indels, bringing HiFi in line with Illumina.
Verily's test is a modified version of Thermo Fisher Scientific's authorized TaqPath COVID-19 Combo Kit that can be used with pooled samples.
The public-private partnership has published a paper on a list of indels larger than 50 bp that is already being used to develop new methods.
Verily is adapting its Project Baseline to study the immune system response to SARS-CoV-2, CNBC reports.
Cerevance, a drug discovery firm employing the transcriptome sequencing method, raised $45 million in Series B financing earlier this month.
The company is also participating in a study, being conducted at Hannover Medical School, investigating the genetics of susceptibility to COVID-19.
The White House earlier this week announced a supercomputer consortium to uncover or develop drugs to address the COVID-19 pandemic, according to NPR.
A trio of Senators were unimpressed with the lack of detail Google provided them regarding Project Nightingale, and they want answers.
Google's Project Nightingale has collected health information on millions of Americans, according to the Wall Street Journal.
A lawsuit alleges the University of Chicago shared medical record data with Google that included information that should not have been, according to the New York Times.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.